Evidence map›Paper›PMID 36126610›Full record

ArticleDrug and alcohol dependence2022

Hours high as a proxy for marijuana use quantity in intensive longitudinal designs.

Brian H Calhoun, Megan E Patrick, Anne M Fairlie, Scott Graupensperger, Katherine Walukevich-Dienst, Christine M Lee

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. When and for whom is enacted stigma associated with alcohol and cannabis use at the event level among sexual and gender minority older adults?Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2025
    Article
  7. Article
  8. Cannabis to cope with COVID-19 in college.Journal of American college health : J of ACH · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Brian H CalhounCenter for the Study of Health and Risk Behaviors, Department of Psychiatry and Behavioral Sciences, University of Washington, Box 357238, Seattle, WA 98195-7238, USA. Electronic address: bhc120@uw.edu.
Megan E PatrickInstitute for Social Research, University of Michigan, P.O. Box 1248, 426 Thompson St., Ann Arbor, MI 48106-1248, USA.
Anne M FairlieCenter for the Study of Health and Risk Behaviors, Department of Psychiatry and Behavioral Sciences, University of Washington, Box 357238, Seattle, WA 98195-7238, USA.
Scott GraupenspergerCenter for the Study of Health and Risk Behaviors, Department of Psychiatry and Behavioral Sciences, University of Washington, Box 357238, Seattle, WA 98195-7238, USA.
Katherine Walukevich-DienstCenter for the Study of Health and Risk Behaviors, Department of Psychiatry and Behavioral Sciences, University of Washington, Box 357238, Seattle, WA 98195-7238, USA.
Christine M LeeCenter for the Study of Health and Risk Behaviors, Department of Psychiatry and Behavioral Sciences, University of Washington, Box 357238, Seattle, WA 98195-7238, USA.
University of Washington · USUniversity of Michigan–Ann Arbor · US

Funding

Intensive Daily Measurement of Simultaneous Alcohol and Marijuana Use in a High-Risk Community Sample of Young Adults: Impacts on Acute and Longer-term Use and ConsequencesR01AA025037 · NIAAA · UNIVERSITY OF WASHINGTON · PI LEE, CHRISTINE M., PATRICK, MEGAN E. · 2016 to 2020
$2.3M
NIAAA NIH HHS R01 AA025037
6 · The paper itself

Abstract

backgroundMeasuring marijuana use quantity in survey research is complicated due to wide variation in the types (e.g., flower, edibles) and potency of marijuana products and in the modes (e.g., smoking, dabbing) used to consume products. There is currently no gold standard marijuana use quantity measure for survey research. This study examined whether number of hours high can be used as a proxy for marijuana use quantity in survey research, particularly in intensive longitudinal designs.

methodsParticipants came from a community sample of young adults participating in a longitudinal study on simultaneous alcohol and marijuana use that used a longitudinal measurement-burst design in which participants completed surveys on up to 14 consecutive days in up to five bursts across nearly two calendar years. Those who reported using marijuana on at least one sampled day were included in present analyses (N = 379; M

resultsWithin persons, mode-specific marijuana use quantity variables predicted same-day number of hours high indicating evidence of initial criterion validity. In turn, hours high predicted same-day negative marijuana-related consequences indicating evidence of proximal predictive validity. Between persons, participants' average number of hours high was positively associated with their odds of possible cannabis use disorder following the last burst demonstrating distal predictive validity.

conclusionsNumber of hours high may be a parsimonious proxy for measuring marijuana use quantity (regardless of mode of use) in survey research, particularly in intensive longitudinal designs.

Indexed as

CannabisHallucinogensMarijuana SmokingMarijuana UseSubstance-Related DisordersAdultFemaleHumansLongitudinal StudiesMaleYoung AdultHallucinogensCannabisIntensive longitudinal dataMarijuanaMeasurement of marijuana useYoung adults

Identifiers

PMID36126610
PMCPMC9749866
OpenAlexW4295137300

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.